(SNCA) pathology, degeneration of nigrostriatal dopaminergic neurons, multifactorial pathogenetic mechanisms and expression of a plethora of motor and non-motor symptoms. Animal models of PD have already been instructive in helping us unravel some of these aspects. However, much remains to be discovered, requiring continued interrogation by the research community. In contrast with the situation for many neurological disorders, PD benefits from of a wide range of available animal models (pharmacological, toxin, genetic and α-synuclein) but this makes selection of the optimal one for a given study difficult. This is especially so when a study demands a model that displays a specific combination of features. While many excellent reviews of ani...
Background Several different animal models are currently used to research the neurodegenerative move...
Animal models of neurological deficits are essential to assess new therapeutic options and reduce tr...
International audienceParkinson's disease is a progressive neurodegenerative disorder mainly charact...
International audienceIdeally, animal models of neurodegenerative diseases should reproduce the clin...
International audienceIdeally, animal models of neurodegenerative diseases should reproduce the clin...
International audienceIdeally, animal models of neurodegenerative diseases should reproduce the clin...
Animal models of Parkinson's disease (PD) have been widely used in the past four decades to investig...
Animal models of Parkinson's disease (PD) have been widely used in the past four decades to investig...
Neurological disorders can be modeled in animals so as to recreate specific pathogenic events and be...
Parkinson’s disease (PD) is a heterogenous disease with a varying age of onset, symptoms, and rate o...
Over the last two decades, significant strides has been made toward acquiring a better knowledge of ...
Parkinson's disease (PD) is a chronic and progressive movement disorder and the second most common n...
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel tre...
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel tre...
Animal models of neurological deficits are essential to assess new therapeutic options and reduce tr...
Background Several different animal models are currently used to research the neurodegenerative move...
Animal models of neurological deficits are essential to assess new therapeutic options and reduce tr...
International audienceParkinson's disease is a progressive neurodegenerative disorder mainly charact...
International audienceIdeally, animal models of neurodegenerative diseases should reproduce the clin...
International audienceIdeally, animal models of neurodegenerative diseases should reproduce the clin...
International audienceIdeally, animal models of neurodegenerative diseases should reproduce the clin...
Animal models of Parkinson's disease (PD) have been widely used in the past four decades to investig...
Animal models of Parkinson's disease (PD) have been widely used in the past four decades to investig...
Neurological disorders can be modeled in animals so as to recreate specific pathogenic events and be...
Parkinson’s disease (PD) is a heterogenous disease with a varying age of onset, symptoms, and rate o...
Over the last two decades, significant strides has been made toward acquiring a better knowledge of ...
Parkinson's disease (PD) is a chronic and progressive movement disorder and the second most common n...
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel tre...
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel tre...
Animal models of neurological deficits are essential to assess new therapeutic options and reduce tr...
Background Several different animal models are currently used to research the neurodegenerative move...
Animal models of neurological deficits are essential to assess new therapeutic options and reduce tr...
International audienceParkinson's disease is a progressive neurodegenerative disorder mainly charact...